Remarkably, the levels of p62 together with LC3B‐II were increased upon treatment with PG and PD in all tested cancer cells in a dose‐dependent manner (Fig. S2), providing evidence that PD is a bona fide autophagy inhibitor. Here, SQSTM1 is linked to cancer.